{"name":"Clinique Saint Jean, France","slug":"clinique-saint-jean-france","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Droleptan","genericName":"Droleptan","slug":"droleptan","indication":"Intra-Operative Nausea and Vomiting","status":"phase_1"}]}],"pipeline":[{"name":"Droleptan","genericName":"Droleptan","slug":"droleptan","phase":"phase_1","mechanism":"D(4) dopamine receptor, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 2A","indications":["Intra-Operative Nausea and Vomiting","Post-Operative Nausea and Vomiting"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1FM1J6Q3VkVl9aOW1xVkhWTEZVNDZocS1OZnpORzl4c2NjSllJYVlPVUtHbXY5ZjhkY2hsUVMzVm05ZElzR1lYQVljRDBsMk1peHNFbzR0NjBrS1lIV2Y0?oc=5","date":"2022-10-29","type":"regulatory","source":"nature.com","summary":"Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema - nature.com","headline":"Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with ","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}